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Abstract 
 
Copy Number Variants (CNVs) at chromosome 17q12 have been associated with a spectrum 
of phenotypes. Deletions of 17q12 are well described and associated with maturity onset 
diabetes of the young type 5 (MODY5) and cystic renal disease (HNF1β) as well as cognitive 
impairment and seizures.  Duplication of 17q12 is emerging as a new genetic syndrome, 
associated with learning disability, seizures and behavioural problems. The duplication is 
often inherited from an apparently unaffected parent. Here we describe a three-generation 
family with multiple individuals carrying a17q12 microduplication with varying clinical 
features, consistent with variable penetrance. The proband who inherited a 1.8 Mb interstitial 
17q12  duplication from his mother presented with developmental delay, behavioural 
problems and mild dysmorphism. One of his sisters, his maternal uncle and his maternal 
grandmother also carry the 17q12 microduplication. Clinical features of the carriers include 
renal problems, diabetes mellitus, learning difficulties, epilepsy and mental illness. Cognitive 
abilities range from normal function to moderate impairment (full-scale IQ range: 52-99). In 
light of recent reports of association of this locus with schizophrenia, we performed a detailed 
psychiatric assessment and confirmed that one family member has symptoms consistent with 
a diagnosis of schizophrenia and another has a prodromal syndrome with attenuated positive 
symptoms of psychosis. This report extends the clinical phenotype associated with the 17q12 
microduplication and highlights the phenotypic variability.  
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Introduction 
 
Recurrent CNVs, typically deletions and reciprocal duplications, occur through nonallelic 
homologous recombination (NAHR) mediated by flanking segmental duplications (Rudd 
etal., 2009).  Recent advances in technology and the routine use of array-CGH for detecting 
small chromosomal copy number changes have enabled detection of several deletion/ 
duplication syndromes. This technology is effective at detecting copy number variants 
(CNVs) throughout the genome. The challenge lies in clinical interpretation of the array-
CGH results which is based on bioinformatic analysis of the region involved and determining 
inheritance of CNVs by parental studies, but crucially involves the detailed phenotyping of 
the affected families.  
 
Recurrent genomic rearrangements of chromosome 17q12 have been associated with varied 
clinical phenotypes.  Deletions of 17q12 are well described and associated with paediatric 
renal disease, maturity onset diabetes of the young type 5 (MODY5) as well as cognitive 
impairment and seizures (Nagamani et al., 2010; Mefford et al., 2007).  
 
The reciprocal duplication of 17q12 is emerging as a new microduplication syndrome with a 
variable clinical phenotype. Neurological symptoms were the most common features 
associated with 17q12 duplications, including learning disability, seizures and brain 
anomalies. Other associated phenotypes observed were behavioural problems, facial 
dysmorphisms and abnormalities of the kidneys, oesophagus and genitalia (Bierhals et al., 
2013).  A recent study also showed that 17q12 duplications are a rare cause of familial fever-
related epilepsy syndromes (Hardies et al., 2013). 
 
A recent whole-genome survey of CNVs in patients with schizophrenia has also identified the 
17q12 duplication as a risk variant for schizophrenia with an odds ratio of 4.16 (Szatkiewicz 
et al., 2014). The recent report of a patient with 17q12 duplication and treatment-resistant 
schizophrenia indicates the need for further studies characterising the range of phenotypes 
associated with 17q12 duplications (Rogdaki et al., 2016).  
 
Here, we describe a three-generation family with multiple individuals carrying 17q12 
microduplication with varying clinical features. Our report adds further clinical data to the 
variable phenotype of patients with 17q12 duplications and aims to provide an overview of 
this condition.  
 
Methods 
A) Patient recruitment and genotyping 
 
The family was recruited through the identification of a 1.8Mb interstitial duplication of 
17q12 in the proband, who was referred to the All Wales Medical Genetics Service for 
assessment of his developmental delay. Parental follow-up FISH studies showed the same 
duplication in his mother. We offered other family members the opportunity to be seen in the 
genetics clinic. We obtained their detailed clinical history and conducted a physical 
examination and initiated FISH studies in the extended family members.  (Figure 1- Family 
pedigree). Patients were recruited to the DEFINE (Defining Endophenotypes From Integrated 
Neuroscience) cohort, for which ethical approval has been obtained from the South East 
Wales Research Ethics Committee, and provided their written informed consent. All reported 
members of the family also provided their written consent to this report and publication of 
their photographs.   
 
B) Psychiatric and psychometric assessment 
 
We conducted a detailed psychiatric assessment, including developmental history, substance 
use history and mental state examination. We supported formal psychiatric diagnoses with 
appropriate diagnostic instruments. We used the PAS-ADD (Psychiatric Assessment 
Schedules for Adults with Developmental Disabilities) (Moss et al., 1997) a diagnostic 
instrument for mental disorders that is also suitable for people with learning difficulties and 
the Structured Clinical Interview (SCID II) for personality disorders (First et al., 1997). We 
used the diagnostic information obtained through the psychiatric interview and the PAS-ADD 
to formulate diagnoses according to the criteria of the DSM5. We also conducted the 
Structured Interview for Prodromal Syndromes (SIPS) to explore the presence of subclinical 
or prodromal psychotic symptoms (Miller et al., 2003). We assessed the severity of current 
psychotic symptoms in maternal uncle (II: 4) with the SAPS and SANS (Scale for the 
Assessment of Positive Symptoms, Scale for the Assessment of Negative Symptoms) 
(Andreasen, 1990) IQ was assessed using the Wechsler Abbreviated Scale of Intelligence 
(WASI), which yields a full-scale intelligence quotient (IQ) and separate scores for the verbal 
and performance domains (Wechsler, 2011). 
 
 
 
 
 
Results  
 
A) Genotyping 
 
We identified a 1.8Mb interstitial duplication of the long arm of chromosome 17 at q12 
(chr17: 34,468,470-36,248,888 according to NCBI Build 37/hg19) (Figure 3a) in the proband 
and 4 other family members (see Figure 1). We thus confirmed a maternally inherited copy 
number gain at 17q12 in the proband. This copy number gain was confirmed by FISH using 
BlueGnome BlueFish probe RP5-986F12 (Figures 3b & 3c). This region encompassed 29 
genes, of which 21 are listed by OMIM (Online Mendelian Inheritance in Man. 
http://www.omim.org) : TBC1D3B, CCL3L1, CCL3L3, YWHAEP6, CCL4L1, TBC1D3C, 
CCL3L1, CCL4L2, TBC1D3H, TBC1D3G, RNU6-1192P, RNA5SP439, ZNHIT3, MYO19, 
PIGW, GGNBP2, DHRS11, MRM1, LHX1, AATF, MIR2909, ACACA, HMGB1P24, 
C17orf78, TADA2A, DUSP14, SYNRG, DDX52, HNF1B, YWHAEP7. (The OMIM Morbid 
genes have been underlined in this list with details summarised in the Discussion section).  
 
 
B) Clinical Reports 
 
Proband (III: 3 see Figure 1) (Figure 2a & b)– The index case is a 20 year old man who is 
the third child of a nonconsanguineous couple and was first seen in the genetics clinic at the 
age of 7 years. His prenatal period was complicated as his mother developed protein losing 
nephropathy with subsequent pre-eclampsia. He was born at 36 weeks gestation with a birth 
weight between 50-75th centile. He was reported to be a content baby but did not breast feed 
and suffered with constipation.  He was noted to have global Developmental Delay (DD) in 
the first few months of life. He sat at the age of 12 months and walked at the age of 19 
months. He had difficulties manipulating small objects, could not skip until 10, only learned 
to tie his shoelaces at 13 and to ride a two wheeled bike at 20 years of age. His speech was 
also significantly delayed with the first meaningful word noted at the age of 2 years, and he 
displayed prominent echolalia. He had difficulties with his coordination whilst growing up 
and received additional support from a home-visiting educational service for children with 
additional support needs (‘portage help’). He attended a special school and did a life skills 
course in college. He currently attends day centres five days a week. He lives with his mother 
and stepfather and has some skills of independent living but needs regular prompting for 
everyday activities. His mother prepares all his meals and organises all his appointments and 
activities.  
 
A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) with autistic tendencies 
was suggested by the mental health team at the age of 3. He has been treated with 
methylphenidate, 10mg twice a day from age 7 until now. He underwent a tonsillectomy at 
the age of 8 years and is on medications for asthma. 
 
His physical examination revealed brachycephaly with right plagiocephaly, a prominent nose, 
triangular face and a marked gap between his upper frontal incisors (Fig 2 a). He also had 
foetal finger pads and fifth finger clinodactyly, bilateral hallux valgus and cubitus valgus. He 
had a small left parasternal café au lait macule. His weight was between the 9-25th centile and 
height on the 50th centile, whereas his occipitofrontal circumference (OFC) measured below 
the 3rd centile. 
 
The initial investigations including a karyotype, testing for Fragile X syndrome, FISH test for 
Smith Magenis syndrome, mutation analysis of ARX gene and telomere analysis were normal. 
CT and MRI scan of the brain and renal ultrasound scan were normal as well.  
 
Detailed psychiatric assessment yielded a diagnosis of Autism Spectrum Disorder (ASD) 
(DSM-5 code: 299.00) and mild-moderate intellectual disability (IQ total: 52; verbal: 55; 
performance: 55). The main features of ASD were deficits in social-emotional reciprocity, 
profound difficulties to develop, maintain, and understand relationships, inappropriate social 
behaviour (hugging and tickling strangers), inflexible adherence to routines,  stereotyped or 
repetitive motor movements (rocking, clapping hands) and speech (repeats same sentence) , 
highly restricted, fixated interests that are abnormal in intensity or focus (spinning tops; 
Thomas the Tank, a series of children’s books and movies), hyper- reactivity to sensory input 
(he does not like to be touched, does not like certain noises such as balloons popping) as well 
as unusual interests in sensory aspects of the environment (touching and smelling objects, 
interest in textures, bright lights). There was no evidence of anxiety disorder (he was reported 
as loving ‘everything scary’, for example balloon rides, thunder and lighting, heights, planes). 
He mentioned hearing voices of family members calling his name and sometimes felt that 
others were watching him, but this did not amount to the full clinical picture of a psychotic 
disorder. 
 
 
 
 
FIGURE 2 Clinical features of the family members. (a and b) Proband (III:3) at age 7 and 19 years, respectively. 
Note the prominent nose and triangular face. (c) Proband’s mother (II:2). (d) Maternal grandmother (I:2). (e) 
Mother’s half-brother (II:4). (f) Proband’s sister (III:2) 
 
 
 
 
FIGURE 3 (a) An expanded view of the oligonucleotide array-CGH showing the duplicated region in 17q12. (b) 
Interphase FISH with probe RP5–986F12 revealed three red signals per nucleus, indicative of a duplication 
(indicated by the arrows). (c) Metaphase FISH with probe RP5–986F12 showing one red signal on the normal 
chromosome 17 and two red signals located very near to each other indicative of a duplication on the other 
chromosome 17 (indicated by the arrow) 
 
Proband’s mother (II: 2 see Figure 1) (Figure 2c) - This 46-year old lady had received a 
diagnosis of focal glomerulonephritis and nephrotic syndrome at the age of 27, with chronic 
renal impairment requiring dialysis and renal transplantation at the age of 31. She underwent 
a tonsillectomy 4 years ago in view of a history of recurrent tonsillitis, a laparoscopic 
cholecystectomy 6 years ago and Basal Cell Carcinoma (BCC) resection 8 years ago.  She 
has mild pulmonary stenosis confirmed on an echocardiogram and is on treatment for 
Diabetes Mellitus Type 2 (DM type 2) and Hypertension (HTN).  
  
She had normal developmental milestones (walking at 13 months; first word at 9 months) and 
no learning difficulties (IQ full-scale: 83; verbal: 78; performance: 90). 
 
She attended mainstream school and left aged 16 without qualifications. She worked as a 
carer and a cleaner but stopped working when her children were born.  
 
She had difficult teenage years with bullying and physical abuse by her classmates, and as a 
consequence developed low mood and suicidal ideas. She suffered severe post-partum 
depression following the birth of her second daughter and also suffered a bout of depression 
during her dialysis. She did not report any history of psychotic or pre-psychotic symptoms 
and did not have a current mood disorder. The personality assessment showed some 
obsessive-compulsive traits.  
 
Maternal grandmother (I: 2 see Figure 1) (Figure 2d) - This lady is 70 years old and had no 
specific educational problems (IQ total: 99; verbal: 108; performance: 88). She suffered 
generalised seizures following an accident as a child, which resolved spontaneously in her 
early teens. She has HTN, DM type 2 and angina (several coronary stents). She had an 
appendectomy.  She suffered a stroke in her late 60s, which has left her with weakness in her 
right arm. Her renal scan was structurally normal.  
 
Following the breakdown of her marriage during her second pregnancy she went through an 
episode of depression. She suffers from Acrophobia (DSM-5 code: 309.29) and had 
Premenstrual Dysphoric Disorder (DSM-5: 625.4) before entering the menopause. During her 
menopause, she suffered from severe mood swings, aggressive outbursts and dissociative 
episodes. 
 
Maternal uncle (II: 4 see Figure 1) (Figure 2e) – The 43 year old half-brother of the 
proband’s mother has a history of developmental delay and had experienced behavioural 
problems since childhood. There were no antenatal problems. He had feeding difficulties in 
infancy, severe constipation and speech delay, hyperactivity and a poor attention span. His 
motor development was normal. He had sleeping problems and motor stereotypes (rocking). 
He had one seizure aged 7 and was on anti-epileptic medication for a few years. He attended 
a special school for pupils with additional learning needs. He had an operation for testicular 
torsion aged 12, and an appendectomy aged 15. He had been assessed for specific language 
impairment, autistic traits and possible psychotic traits. He also has DM type 2, HTN, angina 
and Irritable Bowel Syndrome (IBS). He is being followed-up for chronic renal impairment, 
probably secondary to his poorly controlled diabetes. Renal ultrasound scan revealed no 
abnormality. As reported by his mother, he frequently stops breathing during his sleep; he 
feels tired during the day and frequently falls asleep and chokes. He has recently been 
prescribed a CPAP device.  
 
Psychiatric assessment revealed the presence of schizophrenia (DSM-5 code: 295.90) and 
specific phobia (DSM-5 code: 300.29). His psychotic symptoms included grandiose 
delusions, auditory, visual, olfactory and somato-sensory hallucinations and ego-disturbances 
(for example, he reported feeling other people’s emotions and being able to “get into other 
people’s minds”. (SAPS Composite Score: 59; SANS Composite Score: 35). His main phobic 
symptom was fear of enclosed spaces (claustrophobia). He had a history of a single episode 
of severe depression with attempted suicide by overdosing on prescription medicines (DSM-5 
code: 296.23). His IQ was in the borderline range (IQ total: 76; verbal: 81; performance: 75). 
He is treated with the antipsychotic drug risperidone and with the antidepressant dothiepine. 
 
Proband’s sister (III: 2 see Figure 1) (Figure 2f) – This 27 year old lady was seen in the 
genetics clinic at the age of 24 years. There were no concerns in the antenatal and postnatal 
period. She attended a mainstream school with a statement of special educational needs. (IQ 
total: 79; verbal: 80; performance: 84). She had dyslexia, co-ordination and balance 
difficulties. She developed generalised tonic-clonic seizures at the age of 2 and absence 
seizures in later life. She has been treated with the anticonvulsant carbamazepine for many 
years. Because of her seizures she had to stop working as a cleaner 4 years ago. She had 
plastic surgery on her right ear for cosmetic reasons and to restore symmetry to her face. She 
has been diagnosed with polycystic ovaries and suffers from migraine and episodic dystonia. 
MRI scan of the brain and a renal ultrasound scan were normal.  
 
This lady has experienced episodes of low mood and suicidal thoughts since secondary 
school where she was bullied and suffered physical abuse. She meets diagnostic criteria for 
Generalised Anxiety Disorder (GAD ; DSM-5 code: 300.02), Social Anxiety Disorder (DSM-
5 code: 300.23), Agoraphobia (DSM-5 code: 300.22), Specific Phobia (Arachnophobia; 
DSM-5 code: 309.29) and also Avoidant Personality Disorder (DSM-5 code: 301.82). She is 
currently depressed (Major Depressive Disorder, recurrent; DSM-5 code: 296.32) and has 
obsessive thoughts. She also suffers from dissociative amnestic episodes. She has attenuated 
positive symptoms indicating a prodromal syndrome of psychosis (with overvalued ideas, 
suspiciousness and perceptual abnormalities). 
 
Summary of clinical phenotype (Table I)  
 
Three out of five family members have been diagnosed with DM type 2, two suffered from 
recurrent tonsillitis requiring a tonsillectomy, one female had gallstones and a 
cholecystectomy. Three family members have a history of seizures. One female has 
polycystic ovaries. Only one female had a primary renal problem needing a renal 
transplantation whereas the other four members had normal renal scans.  
 
The index case has ASD (Autism Spectrum Disorder) and ID (Intellectual Disability), his 
maternal uncle suffers from schizophrenia and one of his sisters has attenuated positive 
symptoms of psychosis. Three family members have suffered from episodes of severe to 
moderate depression. The index case’s sister currently fulfils diagnostic criteria for a major 
depressive episode; she also suffers from agoraphobia, generalised anxiety disorder, social 
anxiety disorder and avoidant personality disorder.  
 
All female members of the family seem to be sensitive to hormonal changes with PMDD, 
severe postpartum depression (in two family members) and perimenopausal mood changes 
(in one family member). 
 
Discussion 
 
This three generation family, as well as previously published cases, provides further evidence 
for pathogenicity of the17q12 duplication. Main features include intellectual disability, 
psychosis, autistic spectrum disorder, epilepsy, diabetes, renal disorder and mild dysmorphic 
features. However, there is significant phenotypic variability, and the duplications are 
commonly found in apparently unaffected parents.  
 
Determining the significance of novel CNVs is challenging. Statistically a deletion or 
duplication is deemed pathogenic if it is clearly enriched in affected individuals compared 
with unaffected individuals (Mefford, 2009). The occurrence of a de novo CNV in a 
symptomatic patient is more than likely to be pathogenic, however, deletions and duplications 
can no longer be dismissed because they are inherited from an apparently unaffected parent 
(Mencarelli et al., 2008). Duplication of 17q12 represents a rare copy number variant in the 
normal population and is slightly enriched in patients with intellectual disability, epilepsy and 
schizophrenia (Mefford et al., 2007; Szatkiewicz et al., 2014). Factors such as incomplete 
penetrance, genetic modifiers, epigenetic/environmental factors and difference in size of the 
deletion/duplication may account for the phenotypic variability of the rearrangement 
(Mefford et al., 2007; Mencarelli et al., 2008).   
 
Interrogating the DECIPHER database (Firth et al., 2009); we identified more than 100 
patients with similar duplications of varying sizes, overlapping with or mapping within the 
duplication detected in our family at 17q12. Reviewing the 64 patients for whom phenotypic 
features were available, the majority of the patients were reported as having intellectual 
disability and dysmorphic features. Autism/behavioural problems and seizures were seen in 
15 and 5 patients respectively; psychosis was reported in 1 patient. Multiple renal cysts were 
documented in 3 patients and obesity in 2 patients. Brain anomalies (cerebellar hemisphere 
hypoplasia, agenesis of corpus callosum, abnormal Central Nervous System (CNS) 
myelination), eye problems, microcephaly, hypotonia and short stature were some of the 
other features documented. Out of the 99 cases, the inheritance was unknown in 53 cases 
(53.5%) and in the remaining 46 cases, the duplication was inherited from a parent in 39 of 
them, majority of the parents were reported as having no health problems.  
 
The comparison of the cases of 17q12 duplication reported in the literature and our family 
(Table II) reinforces the diverse spectrum of clinical features associated with this condition. 
The majority of the affected duplication carriers had neurological and psychiatric symptoms 
including developmental delay, learning difficulty, behavioural problems and seizures. These 
patients also shared some facial dysmorphisms like bushy eyebrows, epicanthal folds and thin 
upper lip. Three reported cases of 17q12 duplication were associated with esophageal atresia. 
One of these cases had other symptoms resembling the VATER association, comprising 
Vertebral defects, Anal atresia/stenosis, Tracheo-Esophageal fistula, Radial defects and Renal 
anomalies.  The underlying molecular mechanism of esophageal atresia and VATER 
association is not known. Smigiel et al proposed the role of selected genes such as AATF and 
TADA2L at the 17q12 region in the development of esophageal atresia (Smigiel et al., 2014).  
 
The 17q12 duplication has been reported previously to be associated with autism and 
repetitive behaviours (Bierhals et al., 2013; Brandt et al., 2012). Psychotic symptoms have 
also been described with 17q12 duplication (Nagamani et al., 2010). A Genome wide survey 
by Szatkiewicz et al for CNVs associated with schizophrenia showed an association of 17q12 
duplications with schizophrenia (Szatkiewicz et al., 2014). These findings, in addition to the 
first report of a patient with 17q12 duplication and treatment-resistant schizophrenia 
described by Rogdaki et al (Rogdaki et al., 2016), confirm the association between 17q12 
duplication and schizophrenia. 
 
Deletions in chromosome 17q12, including the HNF1β gene, are associated with cystic renal 
disease and maturity onset diabetes of the young (Mefford et al., 2007). A subset of patients 
with 17q12 duplication reported in the literature as well as one member in our family had 
renal disease. Deletion and duplication rearrangements may convey phenotypes by various 
molecular mechanisms, including altering the copy number of dosage sensitive genes, 
interrupting genes, gene fusion, functional polymorphism and other mechanisms (Lupski and 
Stankiewicz, 2005). This therefore, raises the possibility, whether renal problems and a 
propensity to diabetes mellitus type 2 are a part of the 17q12 duplication syndrome. 
 
Overexpression of the genes in the 17q12 region could explain the associated phenotype, and 
some potential genes have been proposed as candidates for specific phenotypes associated 
with this rearrangement. 5 genes are known to be of some importance in human disease: 
CCL3L1 (susceptibility to HIV/AIDS), ACACA (Acetyl-CoenzymeA Carboxylase Alpha) and 
HNF1B (Non-insulin dependent Diabetes Mellitus, renal cysts and diabetes, renal cell 
carcinoma), PIGW (Hyperphosphatasia with mental retardation syndrome 5) and ZNHIT3 
(PEHO syndrome). The LHX1 gene also maps to this region and is expressed in the human 
brain, thymus and tonsillar tissue. It encodes a transcriptional regulatory protein involved in 
the control of differentiation and development of neural and lymphoid cells (Dong et al., 
1997). Mouse mutants that lack LHX1 function had a severely compromised head formation 
(Shawlot and Behringer, 1995). It is hypothesised that the LHX1 gene is dosage-sensitive and 
may be responsible for some of the neurocognitive (Nagamani et al., 2010) and urogenital 
phenotypes associated with 17q12 rearrangements. The duplication of the ACACA gene in 
the 17q12 region has also been implicated in the generation of neurodevelopmental 
symptoms, including seizures (Hardies et al., 2013). This gene is involved in acetyl-CoA 
metabolism and its duplication would lead to overutilization of acetyl-CoA which could 
result in a global energy failure of the brain. However, a causal role has not been validated 
for any of these genes, and further studies are needed to elucidate candidate genes associated 
with specific clinical features of the 17q12 locus. Also, the possibility of a contiguous gene 
syndrome should be considered.   
 
The full clinical picture associated with 17q12 recurrent duplication is still emerging; 
nevertheless a number of common clinical features including intellectual disability, 
developmental delay, behaviour problems and seizures have emerged. Although there are a 
few shared dysmorphic features noted in these individuals, these features can be variable and 
there are no consistent features of a clinically recognisable syndrome. Psychiatric and 
psychological problems have been reported in a subset of individuals affected with 17q12 
duplication. However, psychological findings of this condition have been poorly 
characterised with no detailed descriptions of the psychiatric phenotype in previous 
publications. We have made detailed psychiatric assessments in our family which further 
substantiates the association of this duplication with schizophrenia and psychotic symptoms; 
thereby emphasising the need for close monitoring of psychological issues in affected 
individuals.  
 
In summary, we add new phenotypic data to the variable spectrum associated with 17q12 
duplication. In this three generation family, predominant clinical features were intellectual 
disability, anxiety and psychotic symptoms, seizures, and mild dysmorphism. Other 
significant associated features were diabetes mellitus and renal impairment, and 
psychological symptoms associated with menstrual changes in all female members of the 
family. This report further supports the pathogenicity of 17q12 duplication and also extends 
the phenotypic spectrum. It also highlights the need to report additional patients with similar 
duplications to further delineate the different clinical features associated with this region and 
ultimately unravel the contribution of the different genes of the locus to the clinical 
phenotype.  
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Patient   Phenotype 
a &b  Proband (III:3) Moderate- severe learning difficulties, ADHD, Autistic Spectrum 
Disorder 
c  Proband’s mother (II:2) 
 
Focal Glomerulonephritis, Nephrotic Syndrome, Renal Transplantation, 
Mild Pulmonary Stenosis, DM type 2, Postpartum Depression  
d Maternal grandmother (I:2) DM type 2, HTN, Angina, Acrophobia, Premenstrual Dysphoric 
Disorder 
e Mother’s half-brother (II:4)  DM type 2, HTN, Obesity, Depression,  Schizophrenia, Specific Phobia 
f  Proband’s sister (III:2) Generalised Anxiety Disorder, Social Anxiety Disorder, Agoraphobia, 
Arachnophobia, Avoidant Personality Disorder, Depression, attenuated 
positive symptoms Epilepsy 
Table I:  Summary of clinical phenotype in our family  
Review of Literature of 17q12 duplication cases:  (Table II)   
 
Reference Sex Size Inheritance Neurological 
features 
Psychiatric 
features 
Dysmorphic 
features 
Other 
This report-  
Proband III: 3 
 
 
 
 
 
 
Proband’s mother II: 2 
 
 
 
 
 
 
Maternal grandmother 
I:2 
 
 
 
 
 
Maternal uncle II: 4 
 
 
 
Proband’s sister III: 2 
 
 
M 
 
 
 
 
 
 
F 
 
 
 
 
 
 
F 
 
 
 
 
 
 
M 
 
 
 
F 
 
1.8Mb 
 
 
 
 
 
 
1.8Mb 
 
 
 
 
 
 
1.8Mb 
 
 
 
 
 
 
1.8Mb 
 
 
 
1.8Mb 
 
 
Maternal 
 
 
 
 
 
 
Maternal 
 
 
 
 
 
 
Unknown 
 
 
 
 
 
 
Maternal 
 
 
 
Maternal 
 
Mild –Mod ID, 
ADHD 
 
 
 
 
       
    ---------- 
 
 
 
 
 
 
 History of stroke 
 
 
 
 
 
 
Borderline ID, 
Childhood epilepsy 
 
 
Borderline ID, 
Childhood 
epilepsy, dyslexia 
 
 
ASD 
 
 
 
 
 
 
Depressive 
episodes, 
Obsessive-
compulsive traits 
 
  
 
Depressive 
episodes, 
Acrophobia, 
Premenstrual 
Dysphoric 
Disorder 
 
Schizophrenia, 
specific phobia, 
depressive episode 
 
Generalised 
Anxiety Disorder, 
Major Depressive 
Disorder 
 
Brachycephaly, 
prominent nose, 
triangular face, 5th 
finger 
clinodactyly, 
hallux valgus 
 
       ------------ 
 
 
 
 
 
 
        ------------ 
 
 
 
 
 
 
        ------------ 
 
 
 
Prominent nose, 
triangular face 
 
 
  Asthma, Tonsillectomy 
 
 
 
 
 
 
Glomerulonephritis, 
Renal Transplantation, 
Tonsillectomy, 
Cholecystectomy, BCC 
excision, Mild Pulmonary 
stenosis, DM type 2, 
HTN 
 
DM type 2,  HTN, 
Angina 
 
 
 
 
 
 
DM type 2, HTN,Obesity, 
Chronic renal impairment 
 
 
Cosmetic surgery on right 
ear to restore symmetry 
of face 
 
 
 
Reference Sex Size Inheritance Neurological 
features 
Psychiatric 
features 
Dysmorphic 
features 
Other 
Mefford et al(2007) 
IMR379 
 
5812 
 
 
6498 
 
F 
 
M 
 
 
F 
 
1.5Mb 
 
1.5Mb 
 
 
Complex 
 
Unknown 
 
Maternal- 
(epilepsy) 
 
Maternal 
(unaffected) 
 
ID 
 
Mild- mod ID, 
Epilepsy 
 
Mild-mod ID,  
Epilepsy 
 
        ---------- 
    
        ---------- 
   
 
        ---------- 
 
        ------------ 
 
        ------------ 
 
 
        ------------ 
 
            -------------- 
 
Focal cortical dysplasia 
 
 
Focal cortical dysplasia 
Mencarelli et al(2008) 
Case 6 
 
M 
 
1.8Mb 
 
Paternal 
(unaffected) 
 
Severe ID 
 
        ---------- 
 
Brachydactyly, 5th 
finger clinodactyly 
 
XX sex reversal, Peter’s 
anomaly, soft palate cleft, 
Atrial septal defect, 
microphthalmia 
Nagamani et al(2010) 
Patient 5 
 
 
 
Patient 6  
 
 
 
Patient 7  
 
 
Patient 8  
 
 
 
Patient 9 
 
M 
 
 
 
M 
 
 
 
F 
 
 
F 
 
 
 
M 
 
1.06- 
2.46Mb 
 
 
1.06- 
2.46Mb 
 
 
1.06- 
2.46Mb 
 
1.06- 
2.46Mb 
 
 
1.06- 
2.46Mb 
 
Unknown 
 
 
 
Maternal (ID- 
Patient 7) 
 
 
Unknown 
 
 
Unknown 
 
 
 
Unknown 
 
        ------------ 
 
 
 
ID 
 
 
 
ID 
 
 
DD 
 
 
 
DD 
 
        ---------- 
 
 
 
Oppositional defiant 
behaviour 
 
 
        ---------- 
 
 
Behaviour problems, 
auditory 
hallucinations 
 
        ---------- 
 
        ------------     
 
 
 
Synorphys, Mild 
syndactyly of 2/3 
fingers and toes 
 
Mild syndactyly of 
2/3 fingers and toes 
 
Small palpebral 
fissures and thin lip 
 
 
Triangular face, 
small palpebral 
fissures, epicanthal 
folds, small mouth 
 
Treacheooesophageal fistula 
with oesophageal atresia, 
Butterfly vertebra at T9 
 
           -------------- 
 
 
 
          -------------- 
 
 
Possible intrauterine drug 
and alcohol exposure 
 
 
Possible intrauterine drug 
and alcohol exposure 
 
 
Reference Sex Size Inheritance Neurological 
features 
Psychiatric 
features 
Dysmorphic 
features 
Other 
Faguer et al (2011) 
 
M 1.42- 2.2 
Mb 
Paternal 
(Bilateral) 
hypoplastic 
kidneys and 
renal transplant) 
        ------------ 
 
 
 
        ------------       
 
       ------------ Esophageal atresia type C, 
Unilateral Multicystic 
hypodysplastic kidney with 
megaureter, bladder 
divertivulae, ectopic testis, 
total epididymis-testis 
dissociation with abnormal 
epididymis head 
Brandt et al (2011) 
 
M 1.4Mb De novo DD, ID Behaviour problems, 
ASD 
Bilateral parietal 
bossing, bushy 
eyebrows, thick 
eyelashes, 
epicanthal folds, 
hypertelorism, thin 
upper lip, 
posteriorly rotated 
ears, small and 
separated teeth 
 
2 Café’ au lait macules, 
Mildly enlarged ventricles 
on Cranial MRI 
Bierhals et al (2013) 
 
M 1.4Mb Paternal (type 2 
Diabetes 
mellitus) 
DD, seizures, 
hypotonia 
Stereotypical 
movements 
Microcephaly, 
upslanting palpebral 
fissures, strabismus, 
widely spaced teeth 
Joint laxity, brisk tendon 
reflexes and extensor 
plantar responses, Cranial 
MRI- suggested 
Periventricular 
leukomalacia. 
 
Smigiel et al (2014) M 1.4Mb De novo Delayed psychomotor 
development, 
hypotonia 
Normal social 
development 
Mild facial 
dysmorphism, 
thumb hypoplasia, 
short stature  
Oesophageal atresia, 
Tracheo-oesophageal 
fistula, anal atresia, sacral 
bone defect, cryptorchidism 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
